INOCA-NA a Local Prospective Registry
Recruiting now
Conditions studied: Ischemia, Myocardial, Non-Obstructive Coronary Atherosclerosis, Microcirculatory Status, Coronary Microvascular Dysfunction (CMD)
In brief
The present study has the following objectives: 1. To investigate the prevalence of INOCA in patients referring for a clinically indicated coronary angiography (CA) c/o Division of Cardiology - Federico II University Hospital; 2. To stratify in INOCA endotypes patients according to the presence or absence of alternative (i.e. non obstructive CAD) causes of myocardial ischemia detected during CA clinically indicated through physiology tests; 3. to implement a stratified therapy in these patients considering the different INOCA endotypes and evaluate the impact on angina class and quality of life as well as cardiac hospitalization and coronary revascularization during 5 year follow up
Key facts
- Study ID
- NCT06588244
- Run by
- Federico II University
- People needed
- 250
- Starts
- 2024-09-19
- Expected to finish
- 2027-09-01
- Last updated by the study team
- 2025-03-17
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Clinical presentation of chronic ischemic heart dis- ease (IHD), requiring coronary angiography for the diagnosis;
- Absence of obstructive coronary artery disease (CAD) at coronary angiography;
- Age \> 18 years.
- Ability to provide a valid informed consent to the study procedure at the time of baseline evaluation;
You may not qualify if…
- Clinical presentation of acute coronary syndrome (ACS) or cardiogenic shock;
- Presence of obstructive CAD with at least 1 significant coronary artery stenosis, defined as diameterstenosis \>50% and FFR ≤0.80 (or iFR/RFR ≤0.89);
- Previous coronary artery bypass grafting (CABG);
- Left ventricular systolic dysfunction, defined as ejection fraction (EF) \<40%;
- Severe valvular heart disease;
- Pregnant or breastfeeding women
- Known hypersensitivity or contraindication to any of the drugs used for coronary physiology testing (adenosine, nitrates, acetylcholine)
- Inability or unwillingness to provide a valid in- formed consent to the study procedure at the time of baseline evaluation.
Where it is running
- DPT of Advanced Biomedical Sciences — Naples, Italy, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.